Literature DB >> 23026270

Epidemiology of esophageal cancer.

Jason B Wheeler1, Carolyn E Reed.   

Abstract

This article discusses the incidence, geographic differences, and risk factors for the 2 most common cancers of the esophagus: squamous cell and adenocarcinoma.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Year:  2012        PMID： 23026270     DOI： 10.1016/j.suc.2012.07.008

Source DB:  PubMed          Journal:  Surg Clin North Am        ISSN： 0039-6109            Impact factor:   2.741


  65 in total

Review 1.  Postoperative radiation therapy of pT2-3N0M0 esophageal carcinoma-a review.

Authors:  Yijun Luo; Xiaoli Wang; Jinming Yu; Bin Zhang; Minghuan Li
Journal:  Tumour Biol       Date:  2016-09-18

2.  Barrett's adenocarcinoma with esophageal varices successfully treated by endoscopic submucosal dissection with direct varices coagulation.

Authors:  Chise Ueda; Tetsuya Yosizaki; Norio Katayama; Norihiro Okamoto; Hiroki Hashimura; Masanori Matsumoto; Megumi Takagi; Seitaro Ikeoka; Kenji Momose; Takaaki Eguchi; Hiroshi Yamashita; Akihiko Okada
Journal:  Clin J Gastroenterol       Date:  2019-09-26

Review 3.  Esophageal cancer: Risk factors, screening and endoscopic treatment in Western and Eastern countries.

Authors:  María José Domper Arnal; Ángel Ferrández Arenas; Ángel Lanas Arbeloa
Journal:  World J Gastroenterol       Date:  2015-07-14       Impact factor: 5.742

4.  Association between microsomal epoxide hydrolase 1 polymorphisms and susceptibility to esophageal cancer: a meta-analysis.

Authors:  Weixin Zhao; Jianfeng Luo; Xuwei Cai
Journal:  Tumour Biol       Date:  2013-05-17

5.  High dose-rate endoluminal brachytherapy for primary and recurrent esophageal cancer : Experience from a large single-center cohort.

Authors:  Nils H Nicolay; Johanna Rademacher; Jan Oelmann-Avendano; Jürgen Debus; Peter E Huber; Katja Lindel
Journal:  Strahlenther Onkol       Date:  2016-05-31       Impact factor: 3.621

6.  Signet Ring Cell Features are Associated with Poor Response to Neoadjuvant Treatment and Dismal Survival in Patients with High-Grade Esophageal Adenocarcinoma.

Authors:  Daniel Solomon; Muhammad Abbas; Yael Feferman; Riad Haddad; Gali Perl; Yulia Kundel; Sara Morgenstern; Nikolai Menasherov; Hanoch Kashtan
Journal:  Ann Surg Oncol       Date:  2021-03-11       Impact factor: 5.344

7.  Novel stimulation strategy with autologous tumor cells to generate T cell receptor-engineered T cells in esophageal squamous cell carcinoma.

Authors:  Liyi Zhang
Journal:  Thorac Cancer       Date:  2020-03-18       Impact factor: 3.500

8.  Propafenone suppresses esophageal cancer proliferation through inducing mitochondrial dysfunction.

Authors:  Wei-Bin Zheng; Yang-Jia Li; Yang Wang; Jie Yang; Can-Can Zheng; Xiao-Hui Huang; Bin Li; Qing-Yu He
Journal:  Am J Cancer Res       Date:  2017-11-01       Impact factor: 6.166

9.  Targeting Orai1-mediated store-operated calcium entry by RP4010 for anti-tumor activity in esophagus squamous cell carcinoma.

Authors:  Chaochu Cui; Yan Chang; Xiaoli Zhang; Sangyong Choi; Henry Tran; Kumar V Penmetsa; Srikant Viswanadha; Liwu Fu; Zui Pan
Journal:  Cancer Lett       Date:  2018-06-15       Impact factor: 8.679

Review 10.  The pulmonary side of reflux disease: from heartburn to lung fibrosis.

Authors:  Marco E Allaix; P Marco Fisichella; Imre Noth; Bernardino M Mendez; Marco G Patti
Journal:  J Gastrointest Surg       Date:  2013-04-25       Impact factor: 3.452
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.